The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Fukuoka, M., Yano, S., Giaccone, G., Tamura, T., Nakagawa, K., Douillard, J.-Y., Nishiwaki, Y., Vansteenkiste, J., Kudoh, S., Rischin, D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.038 · Cited by 2,874
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
WIDMANN, C., GIBSON, S., JARPE, M. B., & JOHNSON, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,729
Self-citationOlayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
The JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,246
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
Li, S., Schmitz, K. R., Jeffrey, P. D., Wiltzius, J. J. W., Kussie, P., & Ferguson, K. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.003 · Cited by 1,118
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
Arora, A., & Scholar, E. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,014
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-973 · Cited by 951
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate
Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J., & Sturgill, T. W. (1993) · Science · doi:10.1126/science.7694366 · Cited by 919
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
Burgess, A. W., Cho, H.-S., Eigenbrot, C., Ferguson, K. M., Garrett, T. P. J., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., & Yokoyama, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00350-2 · Cited by 909
Induction of NF-κB by the Akt/PKB kinase
Kane, L. P., Shapiro, V. S., Stokoe, D., & Weiss, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80265-6 · Cited by 846
Sun, S.-Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., & Khuri, F. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0917 · Cited by 802
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
The role of BH3-only proteins in the immune system
Strasser, A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1568 · Cited by 621
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y., & Hung, M.-C. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.007 · Cited by 544
FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2
van der Horst, A., Tertoolen, L. G. J., de Vries-Smits, L. M. M., Frye, R. A., Medema, R. H., & Burgering, B. M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401138200 · Cited by 543
Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V., Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S., & Pelicci, P. G. (2005) · Nature Medicine · doi:10.1038/nm1160 · Cited by 516
Lavrik, I., Golks, A., & Krammer, P. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01610 · Cited by 494
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
Amann, J., Kalyankrishna, S., Massion, P. P., Ohm, J. E., Girard, L., Shigematsu, H., Peyton, M., Juroske, D., Huang, Y., Stuart Salmon, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.226.65.1 · Cited by 436
The transcriptional targets of p53 in apoptosis control
Yu, J., & Zhang, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.189 · Cited by 420
Liu, D., Ghiso, J. A. A., Estrada, Y., & Ossowski, L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00072-7 · Cited by 392
ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases
Olayioye, M. A., Beuvink, I., Horsch, K., Daly, J. M., & Hynes, N. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17209 · Cited by 367
Muthuswamy, S. K., Gilman, M., & Brugge, J. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6845 · Cited by 363
Takimoto, R., & El-Deiry, W. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203489 · Cited by 360
Wang, J.-M., Chao, J.-R., Chen, W., Kuo, M.-L., Yen, J. J.-Y., & Yang-Yen, H.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6195 · Cited by 357
Recent advances in the protein kinase B signaling pathway
Woodgett, J. R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.010 · Cited by 351
Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer
Goetz, M. P., Toft, D., Reid, J., Ames, M., Stensgard, B., Safgren, S., Adjei, A. A., Sloan, J., Atherton, P., Vasile, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.119 · Cited by 336
The Hsp90 chaperone complex as a novel target for cancer therapy
Goetz, M. P., Toft, D. O., Ames, M. M., & Erlichman, C. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg316 · Cited by 334
Ihle, N. T., Williams, R., Chow, S., Chew, W., Berggren, M. I., Paine-Murrieta, G., Minion, D. J., Halter, R. J., Wipf, P., Abraham, R., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.763.3.7 · Cited by 313
Stabile, L. P., Lyker, J. S., Gubish, C. T., Zhang, W., Grandis, J. R., & Siegfried, J. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1872 · Cited by 309
The EGF receptor - an essential regulator of multiple epidermal functions.
Jost, M., Kari, C., & Rodeck, U. (2000) · PubMed · Cited by 302
Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer
Chan, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602162 · Cited by 301
Regulation of STAT‐dependent pathways by growth factors and cytokines
Leaman, D. W., Leung, S., Li, X., & Stark, G. R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.14.9002549 · Cited by 297
The ErbB Receptors and their Ligands in Cancer: An Overview
Normanno, N., Bianco, C., Strizzi, L., Mancino, M., Maiello, M., Luca, A., Caponigro, F., & Salomon, D. (2005) · Current Drug Targets · doi:10.2174/1389450053765879 · Cited by 275
Epidermal Growth Factor Protects Epithelial Cells against Fas-induced Apoptosis
Gibson, S., Tu, S., Oyer, R., Anderson, S. M., & Johnson, G. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17612 · Cited by 248
Self-citationThe type III epidermal growth factor receptor mutation
Pedersen, M. W., Meltorn, M., Damstrup, L., & Poulsen, H. S. (2001) · Annals of Oncology · doi:10.1023/a:1011177318162 · Cited by 241
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia
Shankar, D. B., Cheng, J. C., Kinjo, K., Federman, N., Moore, T. B., Gill, A., Rao, N. P., Landaw, E. M., & Sakamoto, K. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.018 · Cited by 239
Chen, C.-S., Weng, S.-C., Tseng, P.-H., Lin, H.-P., & Chen, C.-S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505733200 · Cited by 231
Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M. A., Schlessinger, J., Kerr, I. M., Levy, D. E., & Stark, G. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.369 · Cited by 223
Kothari, S., Cizeau, J., McMillan-Ward, E., Israels, S. J., Bailes, M., Ens, K., Kirshenbaum, L. A., & Gibson, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206666 · Cited by 218
Self-citationKilling cancer cells by flipping the Bcl-2/Bax switch
Cory, S., & Adams, J. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.012 · Cited by 217
The development and clinical use of trastuzumab (Herceptin).
Harries, M., & Smith, I. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090075 · Cited by 196
Src family kinases and HER2 interactions in human breast cancer cell growth and survival
Belsches-Jablonski, A. P., Biscardi, J. S., Peavy, D. R., Tice, D. A., Romney, D. A., & Parsons, S. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204205 · Cited by 185
p53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding Site
Liu, X., Yue, P., Khuri, F. R., & Sun, S.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1195 · Cited by 184
Tolcher, A. W., Chi, K., Kuhn, J., Gleave, M., Patnaik, A., Takimoto, C., Schwartz, G., Thompson, I., Berg, K., D'Aloisio, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2145 · Cited by 166
Macdonald, J. S., McCoy, S., Whitehead, R. P., Iqbal, S., Wade, J. L., Giguere, J. K., & Abbruzzese, J. L. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-2908-y · Cited by 154
Ihle, N. T., Paine-Murrieta, G. D., Berggren, M. I., Baker, A. F., Tate, W. R., Wipf, P., Abraham, R. T., Kirkpatrick, D. L., & Powis, G. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0149 · Cited by 154
Cunnick, J. M., Dorsey, J. F., Standley, T. B., Turkson, J., Kraker, A. J., Fry, D. W., Jove, R., & Wu, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14468 · Cited by 148
Kumar, R., Mandal, M., Lipton, A., Harvey, H. A., & Thompson, C. B. (1996) · PubMed · Cited by 144
Longva, K. E., Pedersen, N. M., Haslekås, C., Stang, E., & Madshus, I. H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21015 · Cited by 142
Mitochondria as cancer drug targets
Don, A. S., & Hogg, P. J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.005 · Cited by 139
Bcl-2 family members and disease
Sorenson, C. M. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.010 · Cited by 129
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
Insinga, A., Monestiroli, S., Ronzoni, S., Carbone, R., Pearson, M. A., Pruneri, G., Viale, G., Appella, E., Pelicci, P. G., & Minucci, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600109 · Cited by 120
Johnson, G. L., Dohlman, H. G., & Graves, L. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.04.004 · Cited by 119
Kiningham, K. K., Yong, X. U., Daosukho, C., POPOVA, B., & Clair, D. K. S. (2000) · Biochemical Journal · doi:10.1042/bj3530147 · Cited by 116
EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL
Stoll, S. W., Benedict, M., Mitra, R. S., Hiniker, A. O., Elder, J. T., & Núñez, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201657 · Cited by 113
Gibson, E. M., Henson, E. S., Haney, N., Villanueva, J., & Gibson, S. B. (2002) · PubMed · Cited by 111
Self-citationShe, Q., Ma, W., Zhong, S., & Dong, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109907200 · Cited by 101
Friess, T., Scheuer, W., & Hasmann, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2642 · Cited by 95
Shetty, S., Gladden, J. B., Henson, E. S., Hu, X., Villanueva, J., Haney, N., & Gibson, S. B. (2002) · APOPTOSIS · doi:10.1023/a:1020031023947 · Cited by 90
Self-citationHenson, E. S., Hu, X., & Gibson, S. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0754 · Cited by 87
Self-citationAtiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells
Amit-Vazina, M., Shishodia, S., Harris, D., Van, Q., Wang, M., Weber, D., Alexanian, R., Talpaz, M., Aggarwal, B. B., & Estrov, Z. E. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602637 · Cited by 86
NFkB-dependent chemoresistance in solid tumors
Arlt, A., & Schäfer, H. (2002) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp40336 · Cited by 78
Henson, E. S., Gibson, E. M., Villanueva, J., Bristow, N. A., Haney, N., & Gibson, S. B. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10597 · Cited by 65
Self-citationAnto, R. J., Manickam, V., & Karunagaran, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301790200 · Cited by 62
Tangled Webs: Evidence of Cross-Talk Between c-Raf-1 and Akt
Jun, T., Gjoerup, O. V., & Roberts, T. M. (1999) · Science Signaling · doi:10.1126/stke.1999.13.pe1 · Cited by 60
Cochet, O., Frelin, C., Peyron, J., & Imbert, V. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.010 · Cited by 55
Lin, H., Chen, C., Li, X., & Chen, B. D. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5417 · Cited by 55
Inhibitors of growth factor signalling
Wakeling, A. E. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01014 · Cited by 55
ras Oncogene Triggers Up-regulation of cIAP2 and XIAP in Intestinal Epithelial Cells
Liu, Z., Li, H., Derouet, M. F., Filmus, J., LaCasse, E. C., Korneluk, R. G., Kerbel, R. S., & Rosen, K. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503724200 · Cited by 54
Ras interference as cancer therapy
Duursma, A. M., & Agami, R. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00040-3 · Cited by 53
Benoît, V., Chariot, A., Delacroix, L., Deregowski, V., Jacobs, N., Merville, M., & Bours, V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2914 · Cited by 41
Nishiguchi, K., Kiyohara, Y., Komada, F., Iwakawa, S., & Okumura, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018978024740 · Cited by 10
Cited by
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity
Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 870
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Karasawa, T., & Steyger, P. S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.012 · Cited by 475
A Directed Protein Interaction Network for Investigating Intracellular Signal Transduction
Vinayagam, A., Stelzl, U., Foulle, R., Plassmann, S., Zenkner, M., Timm, J., Assmus, H. E., Andrade-Navarro, M. A., & Wanker, E. E. (2011) · Science Signaling · doi:10.1126/scisignal.2001699 · Cited by 352
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Plati, J., Bucur, O., & Khosravi‐Far, R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21707 · Cited by 293
Metadata
- Authors
- Henson, E. S., & Gibson, S. B.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 18
- Issue
- 12
- Pages
- 2089-2097
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2093034235
- Cited by
- 300
- References
- 86
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.